Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1986
Stable labelling of serum albumin microspheres with gallium-68B Maziere, C Loc'h, M Steinling, et al.
European Journal of Pharmacology|August 15, 1986
[76Br]bromolisuride: a new tool for quantitative in vivo imaging of D-2 dopamine receptorsB Maziere, C Loc'h, O Stulzaft, et al.
Nuclear Medicine and Biology|January 1, 1994
Preparation and pharmacological characterization of [76Br]-meta-bromobenzylguanidine ([76Br]MBBG)C Loc'h, K Mardon, H Valette, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 1, 1987
In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humansH Cambon, J C Baron, J P Boulenger, et al.
European Journal of Nuclear Medicine|January 1, 1985
Tomographic measurement of cerebral blood flow by the 68Ga-labelled-microsphere and continuous-C15O2-inhalation methodsM Steinling, J C Baron, B Maziere, et al.
Nuclear Medicine and Biology|March 30, 1999
Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatumR M Moresco, C Loc'h, M Ottaviani, et al.
Journal of Neuroscience Methods|March 1, 1988
Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteersA K Jones, S K Luthra, B Maziere, et al.
Arthritis and Rheumatism|February 1, 1991
The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic studyD Duboc, A Kahan, B Maziere, et al.
Experimental Neurology|February 1, 1992
6-[18F]fluoro-L-dopa uptake and [76Br]bromolisuride binding in the excitotoxically lesioned caudate-putamen of nonhuman primates studied using positron emission tomographyP Hantraye, C Loc'H, B Maziere, et al.
Psychopharmacology|January 1, 1989
Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsJ C Baron, J L Martinot, H Cambon, et al.
Pageof 8